MDNA Life Sciences.
Going beyond doubt since 2001.

MDNA Life Sciences is a pioneer in the science of mitochondrial DNA. It’s our mission to create an extensive portfolio of proprietary tests that dramatically improve diagnosis, treatment, prognosis and monitoring. Putting an end to the unnecessary surgical procedures, pain and uncertainty that affect patients across the world.

In 2001 scientists from the Universities of Newcastle in the United Kingdom and Lakehead University, Ontario in Canada collaborated to make the discovery that mitochondrial DNA can be used to identify biomarkers for the recognition of disease in humans. This was the beginning of the MDNA journey. A journey that has led to the creation of a growing portfolio of revolutionary tests for the detection of hard to detect diseases like high-grade prostate cancer and endometriosis.

To see the landmarks that brought us to this point, visit our Company Timeline page.

The Management Team

Chris Mitton

Chris Mitton

Chief Executive Officer

Philip Forte

Philip Forte

Chief Financial Officer

Robert Poulter

Robert Poulter

Chief Business Officer

Jennifer Creed

Jennifer Creed

Chief Development Officer

Andrew Harbottle, <small>PhD</small>

Andrew Harbottle, PhD

Chief Science Officer

Board of Directors

Harry Smart

Harry Smart

Chairman

Robert Thayer, <small>PhD</small>

Robert Thayer, PhD

Director

Robert Boxer

Robert Boxer

Director

Christopher Hill

Christopher Hill

Director